These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20549322)

  • 1. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.
    Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C
    Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque regression - the role of statin therapy.
    Sastry P; Kaski JC
    Drugs Today (Barc); 2010 Aug; 46(8):601-8. PubMed ID: 20830320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and the coronary plaque calcium "paradox": Insights from non-invasive and invasive imaging.
    Ferencik M; Chatzizisis YS
    Atherosclerosis; 2015 Aug; 241(2):783-5. PubMed ID: 26070488
    [No Abstract]   [Full Text] [Related]  

  • 6. Plaque stabilization: Can we turn theory into evidence?
    Libby P; Sasiela W
    Am J Cardiol; 2006 Dec; 98(11A):26P-33P. PubMed ID: 17126677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
    Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
    Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients.
    Clark D; Puri R; Nissen SE
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):873-880. PubMed ID: 33048622
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling cardiac transport and plaque formation.
    Aronis Z; Raz S; Martinez EJ; Einav S
    Ann N Y Acad Sci; 2008 Mar; 1123():146-54. PubMed ID: 18375587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the vulnerable plaque from imaging studies.
    Fenning RS; Wilensky RL
    Curr Atheroscler Rep; 2014 Mar; 16(3):397. PubMed ID: 24477795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of inflammation, statins, and plaque regression.
    Moreno PR; Kini A
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):178-81. PubMed ID: 22340824
    [No Abstract]   [Full Text] [Related]  

  • 13. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Terashima M; Michishita I;
    Coron Artery Dis; 2012 Jun; 23(4):239-44. PubMed ID: 22441135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
    Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
    JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
    Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
    J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
    Yogo M; Sasaki M; Ayaori M; Kihara T; Sato H; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Komatsu T; Momiyama Y; Nagata M; Mochio S; Iguchi Y; Ikewaki K
    Atherosclerosis; 2014 Jan; 232(1):31-9. PubMed ID: 24401214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and regression of atherosclerosis: effects of HMG-CoA reductase inhibitors.
    Bjelajac A; Goo AK; Weart CW
    Ann Pharmacother; 1996 Nov; 30(11):1304-15. PubMed ID: 8913414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque Calcification: Do Lipoproteins Have a Role?
    Akers EJ; Nicholls SJ; Di Bartolo BA
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1902-1910. PubMed ID: 31462089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC
    Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.